| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.071 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |